{"id":"W4414018844","doi":"10.1002/cpdd.1586","title":"Safety and Pharmacokinetics of Long‐Acting Monoclonal Antibodies Tixagevimab and Cilgavimab (AZD7442) in a China Phase 2 Study and Evaluation of Asian Race Effect","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"AstraZeneca","keywords":"Pharmacokinetics; Medicine; Placebo; Adverse effect; Internal medicine; Randomized controlled trial; Gastroenterology; Pharmacology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005888271,0.0002301685,0.000949021,0.0003792128,0.00007274248,0.000007313066,0.0001010387,0.0001057342,0.00007251986],"category_scores_gemma":[0.000491824,0.000192244,0.0000488801,0.000335253,0.0004534643,0.00006109897,0.0003429346,0.0006014564,8.535479e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009304813,"about_ca_system_score_gemma":0.0003919438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009300367,"about_ca_topic_score_gemma":0.00008373048,"domain_scores_codex":[0.9965275,0.0009900717,0.001295905,0.0004792184,0.0004081729,0.0002991615],"domain_scores_gemma":[0.9980107,0.001376966,0.0002090904,0.0001023241,0.000164296,0.0001366444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005262334,0.001963288,0.7054529,0.0005663354,0.0003372926,0.00008675047,0.002208606,0.00001057221,0.002176659,0.000004696355,0.0001336942,0.2817969],"study_design_scores_gemma":[0.02747642,0.0007325509,0.9571075,0.0003158167,0.0003443447,0.00001610742,0.0003376141,0.004158546,0.008895728,0.00003408677,0.0004353381,0.0001459904],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929747,0.002657628,0.000009102213,0.001547059,0.0002477022,0.001748211,0.000007665395,0.000008122393,0.0007998355],"genre_scores_gemma":[0.997112,0.001960962,0.0004534802,0.0001477226,0.00004471688,0.00005205024,0.00001441601,0.000009932892,0.0002047631],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2816509,"threshold_uncertainty_score":0.7839485,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04614544387618751,"score_gpt":0.4838551436213657,"score_spread":0.4377096997451782,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}